yingweiwo

Polyoxyl 40 stearate

Alias: S 1012; S 1004; Polyoxyl 40 stearate
Polyoxyl 100 stearate can be used as pharmaceutical excipients like o/w emulsifiers, solubilizers, ointments and suppository bases.
Polyoxyl 40 stearate
Polyoxyl 40 stearate Chemical Structure CAS No.: 9004-99-3
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Product Description
Polyoxyl 100 stearate can be used as pharmaceutical excipients like o/w emulsifiers, solubilizers, ointments and suppository bases. Pharmaceutical excipients or pharmaceutical auxiliaries refer to other chemical substances other than drug ingredients used in the pharmaceutical process. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients can also affect the absorption, distribution, metabolism, and elimination (ADME) processes of concomitant medications.
Polyoxyl 40 stearate (CAS#: 9004-99-3) is a nonionic surfactant and emulsifier belonging to the family of polyoxyethylene stearates produced by the ethoxylation of stearic acid with polyethylene glycol (PEG) chains. It is commonly used in pharmaceutical formulations as an emulsifier and surfactant. The compound has a molecular formula of C20H40O3 and a molecular weight of 328.54 g/mol. It is available in NF (National Formulary) grade for pharmaceutical applications and is manufactured under current Good Manufacturing Practices (cGMP). Polyoxyl 40 stearate is also known as polyethylene glycol monostearate and is used as an excipient in various drug delivery systems.
Biological Activity I Assay Protocols (From Reference)
Targets
No specific biological target is associated with Polyoxyl 40 stearate as it functions as a pharmaceutical excipient rather than a pharmacologically active ingredient. Its primary role is as a surfactant and emulsifying agent in drug formulations. It reduces surface tension between immiscible phases, facilitating the formation of stable emulsions and improving the solubility and bioavailability of poorly soluble drugs.
ln Vitro
As an excipient, Polyoxyl 40 stearate does not exert direct pharmacological activity in cell-based assays. Its in vitro function is evaluated based on its physicochemical properties, including emulsification efficiency, solubilization capacity, and compatibility with active pharmaceutical ingredients. It is used in cell culture media and formulation development to enhance drug solubility and stability. The compound shows good dispersibility in water and is soluble in toluene, acetone, ether, and ethanol.
ln Vivo
Polyoxyl 40 stearate is not designed for direct in vivo pharmacological activity but is used as a formulation component in orally administered drug products. It functions as an absorption enhancer and emulsifier, improving the oral bioavailability of poorly soluble drugs by facilitating micelle formation and increasing drug dissolution. Its safety and efficacy as an excipient have been well established in numerous pharmaceutical products.
Enzyme Assay
No specific receptor binding assays are applicable as Polyoxyl 40 stearate functions as an excipient. Its physical properties are characterized by standard pharmacopoeial methods: congealing temperature between 37-47°C, acid value not more than 2, hydroxyl value between 25-40. Saponification value: 23-33 mgKOH/g; moisture ≤1.0%; pH (1% aqueous solution): 5.0-7.0; HLB value: 16.5-17.5. These parameters ensure batch-to-batch consistency and quality for pharmaceutical use.
Cell Assay
Cell-based studies involving Polyoxyl 40 stearate typically focus on its effects as a formulation excipient rather than direct cellular activity. Cytotoxicity assays (MTT, LDH release) are performed to assess biocompatibility in various cell lines, including Caco-2 (intestinal epithelial), HepG2 (hepatic), and primary cell cultures. Cells are exposed to varying concentrations of the compound (typically 0.001-1% w/v) for 24-72 hours. Membrane integrity and cell viability are evaluated. Permeability studies using Caco-2 cell monolayers assess its effect on drug transport and paracellular permeability.
Animal Protocol
In vivo studies with Polyoxyl 40 stearate are typically conducted as part of toxicology and safety evaluation for drug formulations. Animal models (rats, dogs) are administered the compound orally or intravenously at doses reflecting intended human exposure levels. Parameters assessed include body weight, food consumption, clinical observations, hematology, clinical chemistry, urinalysis, and gross necropsy with histopathological examination of major organs. Studies follow OECD or ICH guidelines for excipient safety evaluation. Pharmacokinetic studies assess absorption, distribution, metabolism, and excretion of the formulation.
ADME/Pharmacokinetics
Absorption, Distribution and Excretion
These esters are hydrolyzed in the intestine. Fatty acids are absorbed and metabolized; at least the shorter polyoxyethylene residues are also absorbed, but they are excreted in urine in an unchanged form (metabolized to oxalic acid is not detected in the human body).
As a pharmaceutical excipient, Polyoxyl 40 stearate is not intended to be systemically absorbed. It is primarily used in oral and topical formulations. The compound is water-soluble and readily dispersible. In the gastrointestinal tract, it may be partially hydrolyzed to stearic acid and PEG, which are metabolized via normal fatty acid oxidation pathways. The PEG component is excreted renally. Its pharmacokinetic profile is well characterized through extensive use in approved pharmaceutical products.
Toxicity/Toxicokinetics
Interactions
MYRI 32 increased the gastrointestinal absorption of gentamicin after oral administration in rats. In female rats, the sensitivity of feeding tests to detect its carcinogenicity was increased when administered at an earlier age with low doses of 7,12-dimethylbenzo[a]anthracene and a high-fat diet containing 1% polyoxyethylene monostearate.
Polyoxyl 40 stearate is widely recognized as safe for use in pharmaceutical and cosmetic applications. It is listed in the FDA Inactive Ingredients Database and is included in the USP-NF monograph. Acute oral toxicity is low (LD50 > 5 g/kg in rats). It is not considered a skin sensitizer or irritant at typical use concentrations. The compound has a long history of safe use as a food additive and pharmaceutical excipient. No genotoxicity or carcinogenicity concerns have been identified at intended use levels.
References

[1]. The effect of polyoxyethylene stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middlebrook TB medium. Tubercle. 1987 Sep;68(3):209-20.

[2]. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur J Pharm Sci. 2009 Jul 12;37(5):573-80.

[3]. Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate. AAPS J. 2007 Oct 5;9(3):E329-35.

Additional Infomation
Polyoxyl 40 stearate is an octadecanoate composed of 8-40 repeating ethylene oxide units. It is a common ingredient in cosmetics and beauty products, primarily used as a surfactant and emulsifier. It is a nonionic surfactant, emulsifier, and food emulsifier. It is a hydroxyl polyether and octadecanoate.
See also: PEG-10 stearate (note moved to); PEG-150 stearate (note moved to); PEG-40 stearate (note moved to)...See more...
Polyoxyl 40 stearate is also known as polyethylene glycol monostearate and is available in various grades (Type II, NF). It is used in a wide range of pharmaceutical products including tablets, capsules, creams, ointments, and intravenous formulations as an emulsifier, solubilizer, and wetting agent. The compound is manufactured under cGMP conditions in FDA-registered facilities. It complies with USP-NF standards and is approved for use in multiple regulatory jurisdictions.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C20H40O3
Molecular Weight
328.5298
Exact Mass
328.297
CAS #
9004-99-3
Related CAS #
Polyoxyethylene stearate;9004-99-3
PubChem CID
24762
Appearance
White to off-white solid powder
Density
0.9±0.1 g/cm3
Boiling Point
438.4±18.0 °C at 760 mmHg
Melting Point
MP: 30-34 °C /POLYETHYLENE GLYCOL 400 MONOSTEARATE USP XVI/ ; 60.00 to 61.00 °C. @ 760.00 mm Hg
Flash Point
164.6±14.0 °C
Vapour Pressure
0.0±2.4 mmHg at 25°C
Index of Refraction
1.457
LogP
7.85
tPSA
46.53
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
19
Heavy Atom Count
23
Complexity
241
Defined Atom Stereocenter Count
0
SMILES
CCCCCCCCCCCCCCCCCC(=O)OCCO
InChi Key
RFVNOJDQRGSOEL-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(22)23-19-18-21/h21H,2-19H2,1H3
Chemical Name
2-hydroxyethyl octadecanoate
Synonyms
S 1012; S 1004; Polyoxyl 40 stearate
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO : ~100 mg/mL
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0439 mL 15.2193 mL 30.4386 mL
5 mM 0.6088 mL 3.0439 mL 6.0877 mL
10 mM 0.3044 mL 1.5219 mL 3.0439 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us